Interthyr targets tough-to-treat diseases from Athens headquarters
Approaching retirement after 36 years at the National Institutes of Health, Dr. leonard Kohn decided he wasn't finished with his goal to improve life for people suffering from tough-to-treat diseases. That's why he founded Interthyr Corporation in Athens to develop tests and medicines for endocrine diseases, autoimmune-inflammatory diseases and cancer.
Bioscience Breakthroughs in Ohio's Enterprise Appalachia
Bioscience companies represent not only the next wave for the global economy, but also opportunity for dramatic advances in the human experience. Ohio's Enterprise Appalachia region possess strength in biotech that runs broad and deep, with an emphasis on research, development and marketing of pharmaceuticals, diagnostics, bioinformatics, medical devices, medical equipment and other health-related products.
Can Interthyr be Ohio U's next commercialization success story?
Ohio University research officials hope drug development spin-off company Interthyr Corp. is their next big success, following on the heels of Diagnostic Hybrids.